|
Originally published In Press as doi:10.1074/jbc.M502264200 on August 18, 2005
J. Biol. Chem., Vol. 280, Issue 44, 36551-36559, November 4, 2005
Proprotein Covertases Are Responsible for Proteolysis and Inactivation of Endothelial Lipase*
Weijun Jin 1,
Ilia V. Fuki 2,
Nabil G. Seidah 3,
Suzanne Benjannet ,
Jane M. Glick¶, and
Daniel J. Rader 4
From the
Department of Medicine and Center for Experimental Therapeutics and the ¶Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennyslvania 19104-6160 and the Laboratories of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Quebec H2W IR7, Canada
Plasma lipoprotein metabolism is tightly regulated by several members of the triglyceride lipase family, including endothelial lipase (EL) and lipoprotein lipase (LPL). Our previous work suggested that EL is proteolytically processed. In this report, we have used a combination of epitope tagging, mutagenesis, and N-terminal sequencing to determine the precise location of the cleavage site within EL. The cleavage occurs immediately after the sequence RNKR, a known recognition sequence for the proprotein convertase (PC) family. We demonstrate that some PCs, but not all, can proteolytically cleave EL at this site and thereby directly regulate EL enzymatic activity through modulating EL cleavage. Furthermore, specific knockdown of individual PCs proves that PCs are the proteases that cleave EL in human endothelial cells. Interestingly, a homologous site in LPL is also cleaved by PCs. This action is unusual for PCs, which are traditionally known as activators of pro-proteins, and highlights a potential role of PCs in lipid metabolism through their proteolytic processing of lipases.
Received for publication, February 28, 2005
, and in revised form, August 2, 2005.
AddendumDuring the time of preparation of this manuscript, Gauster et al. (51) reported that EL is cleaved by proprotein convertases.
* This work was supported in part by a Scientist Development Grant from the American Heart Association (to W. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental experimental procedures and Fig. S1.
2 Supported by Scientist Development Grants from the American Heart Association.
3 Supported by Canadian Institutes of Health Research Grants MGP-44363 and MGC-64518.
4 Supported by National Institutes of Health Grant HL55323 and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.
1 To whom correspondence should be addressed: BRB II/III, Rm. 646, 421 Curie Blvd., Philadelphia, PA 19104-6160. Tel.: 215-573-7666; Fax: 215-573-8606; E-mail: weijun{at}mail.med.upenn.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N Scamuffa, A Basak, C Lalou, A Wargnier, J Marcinkiewicz, G Siegfried, M Chretien, F Calvo, N G Seidah, and A-M Khatib
Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7
Gut,
November 1, 2008;
57(11):
1573 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mayer, J. Hamelin, M.-C. Asselin, A. Pasquato, E. Marcinkiewicz, M. Tang, S. Tabibzadeh, and N. G. Seidah
The Regulated Cell Surface Zymogen Activation of the Proprotein Convertase PC5A Directs the Processing of Its Secretory Substrates
J. Biol. Chem.,
January 25, 2008;
283(4):
2373 - 2384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wu, L. Zhang, J. Gupta, G. Olivecrona, and T. Olivecrona
A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart
Am J Physiol Endocrinol Metab,
October 1, 2007;
293(4):
E908 - E915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gauster, U. Hiden, A. Blaschitz, S. Frank, U. Lang, G. Alvino, I. Cetin, G. Desoye, and C. Wadsack
Dysregulation of Placental Endothelial Lipase and Lipoprotein Lipase in Intrauterine Growth-Restricted Pregnancies
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2256 - 2263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Benjannet, D. Rhainds, J. Hamelin, N. Nassoury, and N. G. Seidah
The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A: FUNCTIONAL CONSEQUENCES OF NATURAL MUTATIONS AND POST-TRANSLATIONAL MODIFICATIONS
J. Biol. Chem.,
October 13, 2006;
281(41):
30561 - 30572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kato, C. Jeanneau, M. A. Tarp, A. Benet-Pages, B. Lorenz-Depiereux, E. P. Bennett, U. Mandel, T. M. Strom, and H. Clausen
Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis: SECRETION OF FIBROBLAST GROWTH FACTOR 23 REQUIRES O-GLYCOSYLATION
J. Biol. Chem.,
July 7, 2006;
281(27):
18370 - 18377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Essalmani, J. Hamelin, J. Marcinkiewicz, A. Chamberland, M. Mbikay, M. Chretien, N. G. Seidah, and A. Prat
Deletion of the Gene Encoding Proprotein Convertase 5/6 Causes Early Embryonic Lethality in the Mouse
Mol. Cell. Biol.,
January 1, 2006;
26(1):
354 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|